FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

782977003: Larotrectinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3757031016 Larotrectinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3757032011 Larotrectinib en Synonym Active Entire term case insensitive SNOMED CT core module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Larotrectinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Larotrectinib Is a Pyrazole derivative true Inferred relationship Existential restriction modifier
Larotrectinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Larotrectinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Larotrectinib Is a Pyrimidine true Inferred relationship Existential restriction modifier
Larotrectinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Larotrectinib Is a Antineoplastic agent false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing larotrectinib (medicinal product) Has active ingredient True Larotrectinib Inferred relationship Existential restriction modifier 1
Product containing larotrectinib in oral dose form (medicinal product form) Has active ingredient True Larotrectinib Inferred relationship Existential restriction modifier 1
Product containing only larotrectinib in oral dose form (medicinal product form) Has active ingredient True Larotrectinib Inferred relationship Existential restriction modifier 1
Larotrectinib Has active ingredient True Larotrectinib Inferred relationship Existential restriction modifier 1
Larotrectinib sulfate Is modification of True Larotrectinib Inferred relationship Existential restriction modifier
Product containing precisely larotrectinib (as larotrectinib sulfate) 20 milligram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance True Larotrectinib Inferred relationship Existential restriction modifier 1
Larotrectinib 20mg/ml oral solution sugar free Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 20mg/ml oral solution sugar free (Bayer Plc) 100 ml 2 x 50ml bottles Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 20mg/ml oral solution sugar free 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib sulfate Is a True Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 100mg capsules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 25mg capsules Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 25mg capsules 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 100mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 25mg capsules (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 100mg capsules 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 25mg capsules (Bayer Plc) 56 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 20mg/ml oral solution 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc) 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib sulfate Is a False Larotrectinib Inferred relationship Existential restriction modifier
Vitrakvi 20mg/ml oral solution (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier
Larotrectinib 20mg/ml oral solution Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Larotrectinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start